NYSE: JPM · JPMorgan Chase & Co.Enhanced Equity Research · May 21, 2026
Equity Research Report
Analysis by Joseph Lefcoe
Enhanced Equity Research — JPMorgan Chase & Co. (JPM)
Fundamental Analysis -- Bullish: 19% ROE, 14yr dividend streak, diversified revenueTechnical Strategist -- Neutral: Below 200-day SMA at $298; RSI 40.5 suggests oversold potentialRisk Analyst -- Constructive: CET1 at 14.3% provides capital cushion; NII headwinds manageable

JPM

JPMorgan Chase & Co. — Enhanced Equity Research
Current Price
$301.98
Market Cap
$862B
52-Week High
$337.25
52-Week Low
$256.00
BUY
PT $340
+12.6% upside · High conviction
Executive Summary

Investment Thesis

JPMorgan Chase reported a record Q1 2026 net income of $16.5B (EPS $5.94 vs $5.46 consensus, a +8.8% beat) on managed revenue of $50.5B (+10% YoY), with strength across all business lines. Net interest income rose 9% to $25.5B, while noninterest revenue climbed 11% to $25.1B, powered by strong Markets and investment banking activity. The Commercial & Investment Bank delivered $9.0B net income with a 21% ROE, and Asset & Wealth Management grew 12% as AUM reached a record $4.8T. Capital return was robust: $1.50/share quarterly dividend (+7% raise in March) plus $8.3B in net share repurchases. However, management trimmed FY2026 NII guidance to ~$103B from $104.5B, reflecting headwinds from anticipated rate cuts and deposit margin compression. CEO Jamie Dimon cautioned about "complex risks" including geopolitical tensions, private credit vulnerabilities, and potential recession scenarios. At 14.5x trailing earnings and 2.35x book value, JPM trades at a premium to peers but is supported by best-in-class ROE of 19%, a 14-year dividend growth streak, and the most diversified revenue base in banking. Key catalysts include the Q2 earnings report (July 15), CCAR stress test results (June), and Basel III Endgame finalization.

Key Financials

Performance Snapshot

P/E (TTM)
14.5x
Forward P/E
13.9x
ROE (Q1 2026)
19%
CET1 Ratio
14.3%
Dividend Yield
1.99%
Efficiency Ratio
53%
NII Guidance (FY26)
~$103B
Book Value/Share
$128.38

Quarterly Financial Trend

$50.5B
Revenue Q1'26
$16.5B
Net Income Q1'26
$5.94
EPS (Q1'26)
$25.5B
NII Q1'26
Growth Drivers

Key Growth Catalysts

+11% YoY in Q1
Investment Banking & Markets Renaissance
The Commercial & Investment Bank delivered $9.0B net income with 21% ROE in Q1 2026. Global M&A and IPO pipelines are rebuilding from cyclical lows, with JPM ranked #1 in global IB fee share. Markets revenue benefited from elevated volatility. Management expects continued strength in advisory and underwriting as the M&A backlog converts.
$4.8 Trillion
Asset & Wealth Management Scale
AWM net income grew 12% as assets under management reached a record $4.8T, driven by strong net inflows and market appreciation. JPM's wealth management platform is gaining share from wirehouses, with fee-based advisory revenue providing recurring, less cyclical income. International expansion and ultra-high-net-worth client acquisition are key growth vectors.
$12.4B
Capital Return & Shareholder Value
JPM returned $12.4B to shareholders in Q1 2026 alone -- $4.1B in dividends plus $8.3B in net buybacks. The CET1 ratio of 14.3% exceeds the 11.9% regulatory minimum by 240bps, providing substantial excess capital for continued aggressive repurchases. The 14-year dividend growth streak was extended with a 7% increase in March 2026.
2026-04-14
Q1 2026 Earnings Release
Beat: Revenue $50.5B (+10% YoY) vs $48.6B est; EPS $5.94 vs $5.46 est (+8.8% beat). NII guidance trimmed to $103B. Announced $8.3B in buybacks.
2026-06-25
Federal Reserve CCAR Stress Test Results
Annual stress test results determine minimum capital ratios and maximum capital return capacity. Favorable outcome could unlock larger buyback authorization for 2026-2027 cycle.
2026-07-15
Q2 2026 Earnings (Est.)
Consensus expects EPS of ~$5.45 on revenue of ~$49.5B. Key focus: NII trajectory, credit quality trends, CIB pipeline conversion, and updated FY guidance.
2026-09-30
Basel III Endgame Final Rule (Est.)
Final rulemaking expected by end of Q3 2026. Favorable outcome could reduce capital surcharges, freeing significant excess capital for return. Worst-case could constrain buybacks meaningfully.
2026-12-31
Fed Rate Path Resolution
Market expects two rate cuts by year-end to 3.25% upper bound. Faster cuts compress NII; slower cuts or hikes would benefit NII but could signal credit stress. JPM NII guidance assumes 2 cuts.
Earnings & Signals

Forward Estimates, Surprises & Insider Activity

Forward Earnings Estimates

Earnings Surprise Track Record

Q1 2026 Est: $5.46 Act: $5.94 +8.8%
Q4 2025 Est: $4.03 Act: $4.81 +19.4%
Q3 2025 Est: $4.02 Act: $4.37 +8.7%
Q2 2025 Est: $4.51 Act: $4.96 +10.0%

Insider Activity (90 Days)

Net Buying/SellingN/A
Sell/Buy RatioN/A
N/A
Peer Comparison

Relative Valuation vs. Competitors

CompanypricemarketCappeTrailingpeForwardpegRatiorevenueGrowthTTM
JPMorgan Chase301.98$862B14.513.91.93+10%
Bank of America48.5$382B14.212.81.78+6%
Goldman Sachs620$198B17.114.51.35+15%
Wells Fargo78.5$262B13.812.11.55+3%
Citigroup82$155B12.510.20.98+4%
JPM commands a valuation premium (14.5x trailing, 2.35x book) over peers (BAC 14.2x, WFC 13.8x, C 12.5x), justified by its industry-leading 19% ROE versus the peer average of ~11.8%. Goldman Sachs trades at a higher PE (17.1x) reflecting its capital-light IB model recovery. Citigroup offers the best deep-value play (10.2x forward, PEG 0.98) but carries execution risk from its ongoing transformation. JPM's premium is earned through superior diversification, consistent execution, and the strongest capital return profile in the group.
Valuation

Price Targets & Scenarios

ScenarioPrice TargetAssumptionsProbability
Bull Case$390NII exceeds $105B as rate cuts are delayed; CIB delivers record investment banking fees in H2; credit losses remain benign; Basel III Endgame finalized favorably allowing accelerated buybacks; ROE sustains above 20%. Multiple expands to 17x forward earnings.25%
Base Case$340NII comes in at guided ~$103B; moderate fee income growth of 8-10%; credit costs normalize but remain manageable; 2 Fed rate cuts as expected; continued $8-9B quarterly buybacks; ROE of 17-19%. Holds current 15.5x forward multiple.50%
Bear Case$250Recession triggers sharp credit deterioration; NII falls below $98B on aggressive rate cuts; investment banking revenue declines 20%+; Basel III Endgame imposes punitive capital surcharges limiting buybacks; private credit contagion affects wholesale banking. Multiple compresses to 11x.25%

Probability-Weighted Target: $335.00 (+10.9% implied upside)

$335.00
Weighted
Bull $39025%
Base $34050%
Bear $25025%

Analyst Consensus

Wells Fargo
Morgan Stanley
Goldman Sachs
Barclays
7 Buy, 6 Hold, 0 Sell
Technical

Key Levels & Options Intelligence

S/RSupport & Resistance

Support 1
Support 2
200-Day SMA
50-Day SMA
Resistance 1
52-Week High

OptOptions & Sentiment

  • Put/Call OI Ratio: 1.19
  • 30-Day IV: 22.4%
  • Max Pain Strike: $305
  • Call Volume (Recent): Leading Puts
Conviction Analysis

Systematic Conviction Score: 78/100 (High)

82
Analyst Alignment
30%
75
Catalyst Clarity
20%
90
Mgmt Quality
10%
Composite 78/100: Earnings Quality=88 (4/4 beats, +11.7% avg), Growth Trajectory=72 (7% EPS CAGR, CIB cyclical recovery), Valuation=65 (14.5x PE reasonable but 2.35x book is premium), Mgmt Execution=90 (Dimon era, 19% ROE, 14yr div streak), Risk Profile=68 (NII headwinds, credit normalization offset by CET1 buffer)
Risk & Ownership

Risk Assessment & Insider Signals

!Risk Factors

  • Credit Cycle Deterioration / Recession: A recession would drive significant increases in loan loss provisions across consumer and commercial portfolios. Consumer credit card delinquencies have been normalizing from post-COVID lows. Commercial real estate exposure remains a concern. JPM provisioned $3.3B in Q1 -- a recession could push quarterly provisions above $5B.
  • Net Interest Income Compression: FY2026 NII guidance already trimmed to ~$103B from $104.5B. Faster-than-expected rate cuts, intensifying deposit competition, and migration from non-interest-bearing to interest-bearing deposits could erode NII further. Each additional 25bp cut beyond guidance represents ~$800M-$1B annual NII headwind.
  • Basel III Endgame / Regulatory Capital Requirements: Worst-case Basel III Endgame implementation could meaningfully increase risk-weighted assets and GSIB surcharge, constraining JPM's ability to return capital through buybacks. CEO Dimon has publicly warned about the potential drag on lending capacity and competitiveness versus non-bank financial institutions.
  • Private Credit and Non-Bank Contagion: Jamie Dimon has warned that private credit losses 'will be larger than feared.' A dislocation in the $1.5T+ private credit market could generate counterparty risk, force JPM to absorb distressed assets, and create broader financial stability concerns that weigh on bank valuations.
  • Geopolitical / Trade War Escalation: JPM's global CIB operations are exposed to geopolitical disruptions. Escalation in trade wars, sanctions, or regional conflicts could suppress cross-border deal activity, widen credit spreads, and force de-risking of international exposures. Emerging market loan book could face heightened stress.
  • Valuation Premium Erosion: JPM trades at 2.35x book value versus peer average of ~1.4x. This premium is justified by superior ROE and franchise quality, but any execution stumble -- a rogue trading loss, a failed technology initiative, or Jamie Dimon's eventual succession -- could compress the multiple toward peer levels.

OOwnership & Insider Signals

  • Vanguard Group: 9.53% | 265.8M shares | Institutional
  • BlackRock Inc.: 7.59% | 211.6M shares | Institutional
  • State Street Corp.: 5.31% | 148.2M shares | Institutional
  • James S. Crown: 1.32% | 35.4M shares | Individual
  • Institutional Total: 74.75% | ~2.03B shares | Summary
  • Retail Investors: 22.79% | ~619M shares | Summary
Risk Heatmap

Quantified Risk Assessment

Severity Risk Factor Prob. PT Impact
High Medium (30%) -$40 to -$60
High Medium-High (45%) -$20 to -$35
Medium-High Medium (35%) -$25 to -$40
Medium Low-Medium (20%) -$15 to -$30
Medium Medium (30%) -$15 to -$25
Medium Medium-Low (25%) -$20 to -$30
Recommendation

Summary

Price
$301.98
Consensus
Buy
Target
$340
Div Yield
1.99%
ROE
19%
Next Catalyst
Jun 25

Entry Strategy

1
40%
$298-302
Initiate near current levels. Stock trading near 200-day SMA support at $298 with RSI at 40 suggesting oversold conditions. Set limit buy in $298-302 zone for favorable risk/reward.
2
30%
$285-290
Add on weakness toward key support. If credit fears or NII downgrades push the stock toward the $285-290 support zone, accumulate with improved risk/reward.
3
30%
$275-280
Full conviction entry on deep pullback. A move to $275-280 (12.5x forward earnings, ~1.8x tangible book) would represent a rare opportunity to own JPM at a valuation discount. Add final tranche.
IMPORTANT DISCLAIMER: This analysis is for educational and research purposes only. Not financial advice. Past performance does not guarantee future results. Consult qualified financial professionals before making investment decisions. All investments carry risk of loss. The information presented is based on publicly available data as of May 21, 2026.